238 related articles for article (PubMed ID: 28260861)
1. Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA.
Elzeny H; Zhang F; Ali EN; Fathi HA; Zhang S; Li R; El-Mokhtar MA; Hamad MA; Wooley KL; Elsabahy M
Drug Des Devel Ther; 2017; 11():483-496. PubMed ID: 28260861
[TBL] [Abstract][Full Text] [Related]
2. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
3. pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.
Yao Y; Su Z; Liang Y; Zhang N
Int J Nanomedicine; 2015; 10():6185-97. PubMed ID: 26491291
[TBL] [Abstract][Full Text] [Related]
4. Poly(glycerol methacrylate)-based degradable nanoparticles for delivery of small interfering RNA.
Morsi NG; Ali SM; Elsonbaty SS; Afifi AA; Hamad MA; Gao H; Elsabahy M
Pharm Dev Technol; 2018 Apr; 23(4):387-399. PubMed ID: 28347210
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy.
Zheng G; Zhao R; Xu A; Shen Z; Chen X; Shao J
Eur J Pharm Sci; 2018 Jan; 111():492-502. PubMed ID: 29107835
[TBL] [Abstract][Full Text] [Related]
7. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation.
Cervello M; Pitarresi G; Volpe AB; Porsio B; Balasus D; Emma MR; Azzolina A; Puleio R; Loria GR; Puleo S; Giammona G
J Control Release; 2017 Nov; 266():47-56. PubMed ID: 28917533
[TBL] [Abstract][Full Text] [Related]
9. Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.
Guo Y; Zhong T; Duan XC; Zhang S; Yao X; Yin YF; Huang D; Ren W; Zhang Q; Zhang X
Drug Deliv; 2017 Nov; 24(1):270-277. PubMed ID: 28165798
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery.
Zou J; Zhang F; Zhang S; Pollack SF; Elsabahy M; Fan J; Wooley KL
Adv Healthc Mater; 2014 Mar; 3(3):441-8. PubMed ID: 23997013
[TBL] [Abstract][Full Text] [Related]
11. Cationic Mucic Acid Polymer-Based siRNA Delivery Systems.
Pan DW; Davis ME
Bioconjug Chem; 2015 Aug; 26(8):1791-803. PubMed ID: 26154102
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
[TBL] [Abstract][Full Text] [Related]
13. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles.
Lee AL; Wang Y; Cheng HY; Pervaiz S; Yang YY
Biomaterials; 2009 Feb; 30(5):919-27. PubMed ID: 19042015
[TBL] [Abstract][Full Text] [Related]
14. Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma.
Tang X; Chen L; Li A; Cai S; Zhang Y; Liu X; Jiang Z; Liu X; Liang Y; Ma D
Drug Deliv; 2018 Nov; 25(1):1484-1494. PubMed ID: 29916268
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells.
Bondì ML; Botto C; Amore E; Emma MR; Augello G; Craparo EF; Cervello M
Int J Pharm; 2015 Sep; 493(1-2):75-85. PubMed ID: 26211902
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression.
Sun TM; Du JZ; Yao YD; Mao CQ; Dou S; Huang SY; Zhang PZ; Leong KW; Song EW; Wang J
ACS Nano; 2011 Feb; 5(2):1483-94. PubMed ID: 21204585
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional hierarchically assembled nanostructures as complex stage-wise dual-delivery systems for coincidental yet differential trafficking of siRNA and paclitaxel.
Elsabahy M; Shrestha R; Clark C; Taylor S; Leonard J; Wooley KL
Nano Lett; 2013 May; 13(5):2172-81. PubMed ID: 23574430
[TBL] [Abstract][Full Text] [Related]
18. Polymer nanocarrier system for endosome escape and timed release of siRNA with complete gene silencing and cell death in cancer cells.
Gu W; Jia Z; Truong NP; Prasadam I; Xiao Y; Monteiro MJ
Biomacromolecules; 2013 Oct; 14(10):3386-9. PubMed ID: 23992391
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
[TBL] [Abstract][Full Text] [Related]
20. Development of Fully Degradable Phosphonium-Functionalized Amphiphilic Diblock Copolymers for Nucleic Acids Delivery.
Borguet YP; Khan S; Noel A; Gunsten SP; Brody SL; Elsabahy M; Wooley KL
Biomacromolecules; 2018 Apr; 19(4):1212-1222. PubMed ID: 29526096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
